Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide as an objective marker of bladder inflammation in interstitial cystitis treated with cyclosporine
2005-000890-23Phase 2Completed
- Sponsor
- Ingrid Ehrén
- Start
- Aug 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Ingrid Ehrén. Primary endpoint: Bladder inflammation assessed by nitric oxide formation. Started Aug 2005; status: completed.
02
Drugs
cyclosporine
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on 2005-000890-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000890-23.